Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

Trial Profile

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2018

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2018 Status changed from suspended to recruiting.
    • 05 Oct 2018 Status changed from recruiting to suspended due to resources.
    • 31 Aug 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top